Previous 10 | Next 10 |
Invitae (NYSE: NVTA ) is up 18% premarket on light volume after posting better-than-expected Q2 revenue after the close yesterday. Key points: More news on: Invitae Corporation, Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...
Invitae Corporation. (NVTA) Q2 2019 Results Earnings Conference Call August 06, 2019, 04:30 PM ET Company Participants Laura D'Angelo - Investor Relations Sean George - Chief Executive Officer Shelly Guyer - Chief Financial Officer Lee Bendekgey - COO Randy Scott - Executive ...
Gainers: MR +26.4% . GH +22.9% . NVTA +18.3% MTCH +16.6% . SEDG +16.6% . More news on: Montage Resources Corporation, Guardant Health, Inc., Invitae Corporation, Stocks on the move, , News on ETFs Read more ...
The following slide deck was published by Invitae Corporation in conjunction with their 2019 Q2 earnings Read more ...
Invitae (NYSE: NVTA ): Q2 GAAP EPS of -$0.54 misses by $0.07 . More news on: Invitae Corporation, Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...
SAN FRANCISCO , Aug. 6, 2019 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced financial and operating results for the second quarter ended June 30, 2019 . "We have now delivered our 25th quarter of impressive growth in b...
Genetic testing services providers are in the green after UnitedHealthcare instituted coverage for Myriad Genetics' GeneSight test for major depressive disorder. More news on: NeoGenomics, Inc., Invitae Corporation, Biocept, Inc., Healthcare stocks news, Stocks on the move, Read...
SAN FRANCISCO , July 24, 2019 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced the availability of its Detect programs to provide no-charge genetic testing for conditions in which testing is underutilized and can improve diagnosis and t...
SAN FRANCISCO , July 23, 2019 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that it will report its second quarter 2019 financial results on Tuesday, August 6, 2019 and will host a conference call and webcast that day at 4:...
News, Short Squeeze, Breakout and More Instantly...
Labcorp Announces Winning Bid for Select Assets of Invitae PR Newswire Advances Labcorp strategy to launch and scale specialty testing in areas such as oncology and rare diseases Transaction requires court approval, with confirmation expected on May 6, 2024 ...
Invitae Enters into Agreement with Labcorp for Sale of Business PR Newswire – Labcorp Selected as Winning Bidder in Court-Supervised Sale Process, Subject to Court and Regulatory Approvals – – $239 Million Cash Bid Includes Acquisition of Substantial...
Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance PR Newswire – Study findings to be presented at the 2024 American Society of Breast Surgeons Annual Meeting – SAN FRANCISCO , April 11, 2024 /PRNewsw...